Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+16.11%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$42.7B
AUM Growth
+$3.67B
(+9.4%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
2,714
New
352
Increased
1,025
Reduced
1,076
Closed
234
Top Buys
| 1 |
Merck
MRK
|
+$385M |
| 2 |
Johnson & Johnson
JNJ
|
+$300M |
| 3 |
Fortinet
FTNT
|
+$275M |
| 4 |
Rivian
RIVN
|
+$272M |
| 5 |
Netflix
NFLX
|
+$240M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
+$522M |
| 2 |
Tesla
TSLA
|
+$498M |
| 3 |
Nike
NKE
|
+$490M |
| 4 |
Coca-Cola
KO
|
+$357M |
| 5 |
Palantir
PLTR
|
+$289M |
Sector Composition
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 12.61% |
| 3 | Healthcare | 11.89% |
| 4 | Industrials | 10.26% |
| 5 | Financials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
loanDepot
LDI
$733M
| $65.1K | ﹤0.01% |
+18,500
| New | +$65.1K |
|
2377
CytomX Therapeutics
CTMX
$345M
| $63.9K | ﹤0.01% |
41,200
-66,700
| -62% | -$103K |
|
2378
Perimeter Solutions
PRM
$3.26B
| $62.6K | ﹤0.01% |
+13,600
| New | +$62.6K |
|
|
CBD
2379
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $61.8K | ﹤0.01% |
77,289
-19,411
| -20% | -$15.5K |
|
2380
Gaia
GAIA
$146M
| $61.8K | ﹤0.01% |
22,900
-300
| -1% | -$810 |
|
2381
Century Casinos
CNTY
$76.6M
| $61.5K | ﹤0.01% |
12,600
-15,500
| -55% | -$75.6K |
|
|
SOL
2382
Emeren Group
SOL
$97M
| $61.2K | ﹤0.01% |
22,400
+1,600
| +8% | +$4.37K |
|
2383
Bionano Genomics
BNGO
$23.1M
| $60.8K | ﹤0.01% |
+536
| New | +$60.8K |
|
2384
Inovio Pharmaceuticals
INO
$144M
| $59.8K | ﹤0.01% |
9,775
+8,675
| +789% | +$53.1K |
|
2385
Veritone
VERI
$208M
| $59.5K | ﹤0.01% |
32,900
-1,200
| -4% | -$2.17K |
|
2386
Sundial Growers
SNDL
$612M
| $58.9K | ﹤0.01% |
35,900
+2,500
| +7% | +$4.1K |
|
2387
GrowGeneration
GRWG
$88.5M
| $58.2K | ﹤0.01% |
23,200
+4,800
| +26% | +$12K |
|
2388
Traws Pharma
TRAW
$12.9M
| $58.1K | ﹤0.01% |
3,119
-675
| -18% | -$12.6K |
|
2389
Cardiff Oncology
CRDF
$137M
| $58K | ﹤0.01% |
39,200
-1,800
| -4% | -$2.66K |
|
2390
Stoke Therapeutics
STOK
$1.23B
| $57.9K | ﹤0.01% |
11,000
-2,800
| -20% | -$14.7K |
|
2391
Nerdy
NRDY
$155M
| $55.9K | ﹤0.01% |
+16,300
| New | +$55.9K |
|
|
ME
2392
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $55.4K | ﹤0.01% |
+3,030
| New | +$55.4K |
|
|
ELEV
2393
DELISTED
Elevation Oncology
ELEV
| $55.2K | ﹤0.01% |
102,700
+25,900
| +34% | +$13.9K |
|
2394
Karyopharm Therapeutics
KPTI
$55.5M
| $54.7K | ﹤0.01% |
4,213
+1,866
| +80% | +$24.2K |
|
2395
Aquestive Therapeutics
AQST
$594M
| $54.1K | ﹤0.01% |
26,800
-3,300
| -11% | -$6.67K |
|
2396
Protara Therapeutics
TARA
$120M
| $50.7K | ﹤0.01% |
27,018
-800
| -3% | -$1.5K |
|
2397
Fortuna Silver Mines
FSM
$2.41B
| $50.2K | ﹤0.01% |
+13,000
| New | +$50.2K |
|
2398
Adaptive Biotechnologies
ADPT
$1.92B
| $49K | ﹤0.01% |
+10,000
| New | +$49K |
|
2399
Alto Ingredients
ALTO
$89.8M
| $48.7K | ﹤0.01% |
+18,300
| New | +$48.7K |
|
2400
Latham Group
SWIM
$924M
| $48.7K | ﹤0.01% |
+18,500
| New | +$48.7K |
|